Bicalutamide D5
| Product Name | Bicalutamide D5 |
|---|---|
| Alternate Names | Bicalutamide Stable Isotopes, Stable Isotopes of Bicalutamide |
| CAT No. | CS-O-02645 |
| CAS No. | 90357-06-5 (Unlabeled) |
| Category | Stable Isotopes |
| Stock | IN-Stock |
| Mol. Wt. | 435.40 g/mol |
| Mol. For. | C₁₈H₉D₅F₄N₂O₄S |
| Hazardous | This is a Hazardous Compound |
| COA | View Sample COA |
| MSDS | View Sample MSDS |
| Parent API | Bicalutamide |
| Purity | Not less than 95% |
| Therapeutic | Anti-Cancer / Oncology |
| Smileys | FC(F)(C(C=C(NC(C(C([2H])([2H])[2H])(O)C([2H])([2H])[S](=O)(C1=CC=C(F)C=C1)=O)=O)C=C2)=C2C#N)F |
| Canonical Smiles | CC(CS(=O)(=O)C1=CC=C(C=C1)F)(C(=O)NC2=CC(=C(C=C2)C#N)C(F)(F)F)O |
| InchIKey | LKJPYSCBVHEWIU-UHFFFAOYSA-N |
| Inchl | InChI=1S/C18H14F4N2O4S/c1-17(26,10-29(27,28)14-6-3-12(19)4-7-14)16(25)24-13-5-2-11(9-23)15(8-13)18(20,21)22/h2-8,26H,10H2,1H3,(H,24,25) |
| IUPAC | N-[4-cyano-3-(trifluoromethyl)phenyl]-3-(4-fluorophenyl)sulfonyl-2-hydroxy-2-methylpropanamide |
| Controlled | No |
| Shipping | Free for purchase above 1000$ |
| Delivery | In-Stock, products will be dispatched within 24 hours via FedEx for USA, Europe, and other countries. |
| Return | Returns/replacement accepted if you are not satisfied with the quality of the product, (please send us an email with the reason/issues which are facing, within 15 days, after receipt of the product). |
| Ordering | Place your order online or by email sales@clearsynth.com |
Bicalutamide D5 is a synthetic non-steroidal anti-androgen drug, which is used to treat prostate cancer. It is a deuterated analog of Bicalutamide, which means that five hydrogen atoms in the molecular structure of Bicalutamide are replaced with deuterium atoms. This modification increases the stability of the compound and also improves its pharmacological properties.
The drug works by blocking the action of male hormones, called androgens, which are responsible for the growth of prostate cancer cells. Bicalutamide D5 binds to androgen receptors in the prostate gland, preventing the androgens from binding to them. As a result, the cancer cells are unable to grow and divide, and the tumor size is reduced.
Bicalutamide D5 is administered orally in the form of tablets, usually once daily. The dosage and duration of treatment depend on the severity of the cancer and the patient's response to the drug. It is important to take the medication at the same time each day to ensure its effectiveness.
The chemical formula of Bicalutamide D5 is C18H14D5F4N3O4S, and its molecular weight is 422.5 g/mol. It is a white to off-white powder, which is sparingly soluble in water. The drug is metabolized in the liver, and its metabolites are excreted in the urine and feces.
In conclusion, Bicalutamide D5 is an effective anti-androgen drug, which is used to treat prostate cancer. Its deuterated analog has improved pharmacological properties and is a valuable tool for research in drug development.
Get an Instant Quote
Related Compounds
S-(+)-Bicalutamide-d4 | Bicalutamide-d4 |